Clin2
NCT07792538Possibly a fitNot yet recruiting

Psilocybin therapy for veterans with PTSD

Posttraumatic Stress Disorder (PTSD)

Part of Mental health clinical trials.

This study tests whether psilocybin (a psychedelic substance) combined with psychotherapy can help veterans with PTSD who haven't improved with standard treatments. The treatment involves a few sessions where you take psilocybin under supervision.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
12 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You are a Dutch Armed Forces veteran.
  • You have been diagnosed with PTSD and standard treatments haven't helped enough.
  • You can read and speak Dutch fluently.
  • You are able to swallow pills and have a body mass index (BMI) over 18.
  • You agree to have study visits recorded and provide a contact person.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06954025Enrolling by invitation· Phase 2
MDMA therapy for PTSD inpatients

This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.

Oegstgeest
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas
NCT06989957Recruiting· Phase 1
Psilocybin and MDMA therapy for PTSD in veterans

This study tests whether a combination of two investigational drugs, psilocybin and MDMA, can help veterans with post-traumatic stress disorder (PTSD). You would receive the drugs in a controlled setting and be monitored closely.

Baltimore, Maryland
NCT07737054Recruiting· Early Phase 1
Psilocybin therapy for PTSD

This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.

Tel Aviv
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06386003Recruiting· Phase 2
Psilocybin and talk therapy for chronic PTSD

This trial tests whether a medication called psilocybin (the active ingredient in magic mushrooms) can help people with long-term PTSD when combined with a specific type of talk therapy. The goal is to see if this approach reduces PTSD symptoms more than therapy alone.

Toronto, Ontario

Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.